C.C.M. PHARMA(SRL)

BE 0475.754.613

Financial data from C.C.M. PHARMA

	2023		2022		2021		2020
Profit/Loss Section 9904: Profit/Loss of the financial year (after taxes on result) (+/-)	€ 50.316	-39%	€ 82.843	451%	€ 15.048	0%	€ 15.102
Equity Section 10/15: Equity consists of capital, capital reserves and earnings that remain within the company. These are fully owned by the company and are at its disposal to cover its risks. The better the ratio between equity and debts, the more solvent a company is. A positive equity ratio is important. A negative equity ratio (because of accumulated losses) is a severe warning sign that the continuity of the company may be threatened.	€ 172.492	41%	€ 122.175	211%	€ 39.332	62%	€ 24.283
Gross margin Section 9900: Gross margin or added value is net sales minus the direct costs of the goods sold. In other words: sales invoices minus purchase invoices (70/74 – 60/61). A negative gross margin is a warning sign especially when occurring over several years. It may indicate that the company has insufficient means to cover internal costs like salaries, etc.	€ 87.565	-36%	€ 136.236	498%	€ 22.779	17%	€ 19.400

Publications in the Belgian Official Journal from C.C.M. PHARMA

	Date	Publication
	04-07-2024	Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Designation - Resignations - Appointments - General meeting (NL)
	30-12-2014	Registered Office - Resignations - Appointments (NL)
	03-07-2012	Registered Office - Resignations - Appointments (NL)
	09-10-2006	Registered Office Relocation (FR)
	03-10-2005	Registered Office Relocation (FR)

Frequently asked questions

What is the VAT number of Communication Consulting Marketing Pharma?

The VAT number of Communication Consulting Marketing Pharma is BE0475754613.

When was Communication Consulting Marketing Pharma founded?

Communication Consulting Marketing Pharma was founded on 27-09-2001.

What is the address of Communication Consulting Marketing Pharma?

The current registered office of Communication Consulting Marketing Pharma is located at Brabants Dal 15, 1780 Wemmel.

When was the last time Communication Consulting Marketing Pharma filed their annual financial statements?

The most recent financial statements of Communication Consulting Marketing Pharma were filed on 28-06-2024. You can view them here.

How many employees does Communication Consulting Marketing Pharma have?

There are currently no employees working at Communication Consulting Marketing Pharma or no workforce information is available.

What is the annual turnover of Communication Consulting Marketing Pharma?

At the time of its most recent financial statements, Communication Consulting Marketing Pharma did not publish any turnover figures. Communication Consulting Marketing Pharma reported a gross margin of €87,565.06.